Ethical aspects of fecal microbiota transplantation (fmt)

European Review for Medical and Pharmacological Sciences

Volumn 19, Issue 17, 2015, Pages 3173-3180

  Daloiso, V ^a   Minacori, R ^a   Refolo, P ^a   Sacchini, D ^a   Craxi L ^b   Gasbarrini, A ^a   Spagnolo, A G ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Donor.; Ethics; Fecal microbiota transplantation; Innovative therapeutic procedure

Indexed keywords

ABDOMINAL CRAMP; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; CLOSTRIDIUM DIFFICILE INFECTION; CONSTIPATION; DIARRHEA; DONOR SELECTION; ENTERITIS; FECAL MICROBIOTA TRANSPLANTATION; FECES ANALYSIS; HUMAN; HUMAN MICROBIOME RESEARCH; INFLAMMATORY BOWEL DISEASE; INFORMED CONSENT; IRRITABLE COLON; MEDICAL ETHICS; MEDICAL RESEARCH; METHODOLOGY; MICROBIOLOGICAL PHENOMENA AND FUNCTIONS; MICROBIOTA FINGERPRINT; NONHUMAN; PATIENT SAFETY; PERITONITIS; PRACTICE GUIDELINE; RISK BENEFIT ANALYSIS; TREATMENT RESPONSE; ULCERATIVE COLITIS; UPPER GASTROINTESTINAL BLEEDING; BIOLOGICAL THERAPY; DONOR; ETHICS; PROCEDURES;

BIOLOGICAL THERAPY; FECAL MICROBIOTA TRANSPLANTATION; HUMANS; TISSUE DONORS;

EID: 84973437282     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. MENG-QUE X, HAI-LONG C, WEI-QIANG WQ, WANG S, XIAO-CANG C, FANG Y, BAMG-MAO W. Fecal microbiota transplantation broadening its applications beyond intestinal disorders. World J Gastroenterol 2015; 21: 102-111.
2. PURCHIARONI F, TORTORA A, GABRIELLI M, BERTUCCI G, GIGANTE G, IANIRO G, OJETTI V, SCARPELLINI E, GSBARRI-NI A. The role of intestinal microbiota and the immune system. Eur Rev Med Pharmacol Sci 2013; 17: 323-333.
3. COMPARE D, NARDONE G. The role of gut microbiota in the pathogenesis and management of allergic diseases. Eur Rev Med Pharmacol Sci 2013; 17(2 suppl: 11-17.
4. GUINANE CM, COTTER PD. Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ. Therap Adv Gastroenterol 2013; 6: 295-308.
5. KOOTTE RS, VRIEZE A, HOLLEMAN F, DALLINGA-THIE GM, ZOETENDAL EG, DE VOS WM, GROEN AK, HOEKSTRA JB, STROES ES, NIEUWDORP M. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus. Diabetes Obes Metab 2012; 14: 112-120.
6. SOMMER F, BACKHED F. The gut microbiota - Master of host development and physiology. Nat Rev Microbiol 2013; 2: 227-238.
7. DOMINGUEZ-BELLO M, COSTELLO EK, CONTRERAS M, MAGRIS M, HIDALGO G, FIERER N, KNIGHT R. Delivery mode shapes the acquisition and structures of the initial microbiota across of multiple body habitats in newborns. PNAS 2010; 11: 11971-11975.
8. LEDERBERG J, MCCRAY AT. "Ome Sweet" Omics-A genealogical treasury of words. Scientists 2001; 15: 8.
9. THE NIH HMP WORKING GROUP. The NIH Human Microbiome Project. Genome Res 2009; 19: 2317-2323.
10. THE HUMAN MICROBIOME PROJECT CONSORTIUM. Structure, function and diversity of the healthy human microbioma. Nature 2012; 486: 207-214.
11. PROCTOR LM. The Human Microbiome Project in 2011 and beyond. Cell Host Microbe 2011; 10; 287-291.
12. SLASHINSKI MJ, WHITNEY SN, ACHENBAUM LS, KEITEL WA, MC CURDY SA, MC GUIRE AL. Investigator's perspectives on Translating Human Microbiome Research into Clinical Practice. Public Health Genomics 2013; 16: 127-133.
13. JUENGST E, HUSS J. From metagenomics to the metagenome: conceptual changes and the rhetoric of translational genomic research. Genomics, Society and Policy 2009; 15: 1-19.
14. TREMAROLI V, BACKED F. Functional interaction between the gut microbiota and host metabolism. Nature 2012; 489: 242-249.
15. MILLS KHG. TLR-dependent T cell activation in autoimmunity. Nat Rev Immunol 2011; 11: 807-822.
16. SEKIROV I, RUSSELL SL, ANTUNES LC, FINLAY BB. Gut microbiota in health and disease. Physiol Rev 2010; 90: 859-904.
17. DUPONT AW, DUPONT HL. The intestinal microbiota and chronic disorders of the gut. Nat Rev Gastroenterol Hepatol 2011; 8: 523-531.
18. OHMAN L, SIMRÉN M. Intestinal microbiota and its role in irritable bowel syndrome (IBS. Curr Gastroenterol Rep 2013; 15: 323.
19. CAMMAROTA G, IANIRO G, CIANCI R. BIBBÒ S, GASBARRI-NI A, CURRÒ D. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: Potential for therapy. Pharmacol Ther 2015; 149: 191-212.
20. ZHU Q, GAO R, WU W, QIN H. The role of gut microbiota in the pathogenesis of colorectal cancer. Tumour Biol 2013; 34: 1285-1300.
21. ARON-WISNEWSKY J, GABORIT B, DUTOUR A, CLEMENT K. Gut microbiota and non-alcoholic fatty liver disease: new insights. Clin Microbiol Infect 2013; 19: 338-348.
22. DHIMAN RK. Gut microbiota and hepatic encephalopathy. Metab Brain Dis 2013; 28: 321-326.
23. KOVATCHEVA-DATCHARY P, ARORA T. Nutrition, the gut microbiome and the metabolic syndrome. Best Pract Res Clin Gastroenterol 2013; 27: 59-72.
24. EVERARD A, CANI PD. Diabetes, obesity and gut microbiota. Best Pract Res Clin Gastroenterol 2013; 27: 73-83.
25. RUSSELL SL, FINLAY BB. The impact of gut microbes in allergic diseases. Curr Opin Gastroenterol 2012; 28: 563-569.
26. IEBBA V, ALOI M, CIVITELLI F, CUCCHIARA S. Gut microbiota and pediatric disease. Dig Dis 2011;29: 531-539.
27. GUO B, HARSTALL C, LOUIE T, VELDHUYZEN VAN ZANTEN, DIELMAN LA. Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated disease. Aliment Pharmacol Ther 2012; 35: 865-875.
28. CAMMAROTA G, IANIRO G, GASBARRINI A. Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review. J Clin Gastroenterol 2014; 48: 693-702.
29. ANDREWS P, BORODY T. Bacteriotherapy for chronic constipation-a long term follow up. Gastroenterology 1995; 108: A563.
30. GOUGH E, SHAIKH H, MANGES AR. Systematic review of intestinal microbiota transplantation (Fecal Bacteriotherapy for recurrent Clostridium difficile infection. Clin Infect Dis 2011; 53: 994-1002.
31. YOUNGSTER I, RUSSELL GH, PINDAR C, ZIV-BARON T, SAUK J, HOHMANN EL. Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. JAMA 2014; 313: 1772-1778.
32. VYAS D, AEKKA A, VYAS A. Fecal transplant policy and legislation. World J Gastroenterol 2015; 21: 6-11.
33. HAWKINS AK, O'DOHERTY KC. "Who owns your poop?": Insights regarding the intersection of human micro-biome research and the ELSI aspects of biobanking and related studies. BMC Med Genomics 2011; 4: 72.
34. MCGUIRE AL, COLGROVE J, WHITNEY SN, DIAZ MC, BUSTILLOS D, VERSALOVIC J. Ethical, legal, and social considerations in conducting the Human Microbiome Project. Genome Res 2008; 18: 1861-1864.
35. MCGUIRE AL, ACHENBAUM LS, WHITNEY SN, SLASHINSKI MJ, VERSALOVIC J, KEITEL WA, MCCURDY SA. Perspectives on human microbiome research ethics. J Empir Res Hum Res Ethics 2012; 7: 1-14.
36. GREGORY JC, BUFFA JA, ORG E, WANG Z, LEVISON BS, ZHU W, WAGNER MA, BENNETT BJLI L, DIDONATO JA, LUSIS AJ, HAZEN SL. Transmission of atherosclerosis susceptibility with gut microbial transplantation. J Biol Chem 2014; 290: 5647-5660.
37. BRANDT LJ, ARONIADIS OC. An overview of fecal microbiota transplantation: techniques, indications, and outcomes. Gastrointest Endosc 2013; 78: 240-249.
38. VAN NOOD E, VRIEZE A, NIEUWDORP M, FUENTES S, ZOETENDAL EG, DE VOS WM, VISSER CE, KUIJPER EJ, BARTELSMAN JF, TIJSSEN JG, SPEELMAN P, DIJKGRAAF MG, KELLER JJ. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013; 368: 407-415.
39. BAKKEN JS, BORODY T, BRANDT LJ, BRILL JV, DEMARCO DC, FRANZOS MA, KELLY C, KHORUTS A, LOUIE T, MAR-TINELLI LP, MOORE TA, RUSSELL G, SURAWICZ C. Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol 2011; 9: 1044-1049.
40. KASSAM Z, LEE CH, YUAN Y, HUNT RH. Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol 2013; 108: 500-508.
41. BORODY TJ, KHORUTS A. Fecal microbiota transplantation and emerging applications. Nat Rev Gastroenterol Hepatol 2012; 9: 88-96.
42. VERMEIRE S, JOOSSENS M, VERBEKE K, HILDEBRAND F, MACHIELS K, VAN DEN BROECK K, VAN ASSCHE G, RUT-GEERTS PJ, RAES J. Pilot study on the safety and efficacy of faecal microbiota transplantation in refractory Crohn's disease. Gastroenterology 2012; 142: S360.
43. SURAWICZ CM, BRANDT LJ, BINION DG, ANANTHAKRISH-NAN AN, CURRY SR, GILLIGAN PH, MCFARLAND LV, MEL-LOW M, ZUCKERBRAUN BS. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 2013; 108: 478-498.
44. ANDERSON JL, EDNEY RJ, WHELAN K. Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease. Aliment Pharmacol Ther 2012; 36: 503-516.
45. ANGELBERGER S, REINISCH W, MAKRISTATHIS A, LICHTEN-BERGER C, DEJACO C, PAPAY P, NOVACEK G, TRAUNER M, LOY A, BERRY D. Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation. Am J Gastroenterol. 2013; 108: 1620-1630.
46. QUERA R, ESPINOZA R, ESTAY C, RIVERA D. Bacteremia as an adverse event of fecal microbiota transplantation in a patient with Crohn's disease and recurrent Clostridium difficile infection. J Crohns Colitis 2014; 8: 252-253.
47. VRIEZE A, VAN NOOD E, HOLLEMAN F, SALOJARVI J. KOOTTE RS, BARTERLSMAN JF, DALLINGA-THIE GM, ACKERMANS MT, SERLIE MJ, OOZEER R, DERRIEN M, DRUESNE A, VAN HYLCKAMA VIELEG JE, BLOKS VW, GROEN AK, HEILIG HG, ZOETENDAL EG, STROES ES, DE VOS WM, HOEKSTRA JB, NIEVWDORP M. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 2012; 143: 913-916.
48. BORODY TJ, LEIS S, CAMPBELL J, TORRES M, NOWAK A. Fecal microbiota transplantation (FMT in multiple sclerosis (MSs. Am J Gastroenterol 2011; 106: S352.
49. ANATHASWAMY A. Faecal transplant eases symptoms of Parkinson's. New Scientist 2011; 2796: 8-9.
50. BORODY TJ, NOWAK A, TORRES M, CAMPBELL J, FIN-LAYSON S, LEIS S. Bacteriotherapy in chronic fatigue syndrome (CFS: a retrospective review. Am J Gastroenterol 2012; 107: S591- S592.
51. BORODY TJ, CAMPBELL J, TORRES M. Reversal of idiopathic thrombocytopenic purpura (ITP with fecal microbiota transplantation (FMT [abstract]. Am J Gastroenterol 2011; 106: S352.
52. FIERER N, LAUBER CL, ZHOU N, MC DONALD D, KOSTEL-LO EK, KNIGHT R. Forensic identification using skin bacterial communities. Proc Natl Acad Sci USA 2010; 107: 6477-6481.
53. TRIDICO SR, MURRAY DC, ADDISON J, KIRBRIDE KP, BUNCE M. Metagenomic analyses of bacteria on human hairs: a qualitative assessment for applications in forensic science. Investig Genet 2014; 5: 16.
54. SLASHINSKI MJ, MCCUEDY SA, ACHENBAUM LS, WHITNEY SN, MCGUIRE AL. "Snake-oil", "quack medicine", and "industrially cultured organism": biovalue and the commercialization of human microbiome research. BMC Medical Ethics 2012; 13: 28.
55. SHARP RR, ACHKAR JP, BRINICH MA, FARRELL RM. Helping patient make informed choices about probiotics: a need for research. Am J Gastroenterol 2009; 104: 809-813.
56. MINACORI R REFOLO P, SACCHINI D, SPAGNOLO AG. Research Ethics Committees and clinical research in Italy: where are we going? Eur Rev Med Pharmacol Sci 2015; 19: 481-485.
57. DREKONJA, D, REICH J, GEZAHEGN S, GREER N, SHAUKAT A, MAC DONALD R, RUTKS I, WILT TJ. Fecal microbiota transplantation for clostridium difficile infection: a systematic review. Ann Intern Med. 2015;162: 630-638.